Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Savella price, strengths & recalls

Brand of milnacipran (generic)

Pharmacies pay $244.50 for 30 tablets of Savella 100 mg tablet this week, and from $8.15 to $245.15 across its 5 priced strengths and forms. The generic, milnacipran, costs pharmacies from $36.45. Its official label last changed on August 27, 2026.

Brand
Pharmacies pay$244.50for 30 tablets of 100 mg tabletNo change in 4 weeks
Fair cash price
$291.68
Strengths
5
Makers
1
Updated
Nov 11

Savella price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
4-week titration pack Brand$8.15$8.15 / 1 kit+0.1%-0.2%
12.5 mg tablet Brand$8.17$245.15 / 30 tablets+0.1%+0.3%
25 mg tablet Brand$8.15$244.52 / 30 tablets-0.1%-0.1%
50 mg tablet Brand$8.16$244.68 / 30 tabletsNo change-0.1%
100 mg tablet Brand$8.15$244.50 / 30 tabletsNo change-0.1%

The lowest cost per tablet is 100 mg tablet at $8.15. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Savella vs generic milnacipran

Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:

StrengthBrandGenericBrand costs
12.5 mg tablet$245.15$36.456.7x
25 mg tablet$244.52$71.523.4x
50 mg tablet$244.68$84.902.9x
100 mg tablet$244.50$81.813x
GenericMilnacipran prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recallsNone on record

What did you pay for savella? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedAugust 27, 2026
Version41 of 29
EffectiveSep 10, 2025
Read the label

These highlights do not include all the information needed to use SAVELLA safely and effectively. See full prescribing information for SAVELLA. SAVELLA® (milnacipran HCl) tabletsInitial U.S. Approval: 2009

This drug has a boxed warning

WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS

SAVELLA is a selective serotonin and norepinephrine reuptake inhibitor (SNRI), similar to some drugs used for the treatment of depression and other psychiatric disorders. Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of such drugs in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on SAVELLA should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. SAVELLA is not approved for use in the treatment of major depressive disorder. SAVELLA is not approved for use in pediatric patients [see Indications and Usage (1), Warnings and Precautions (5.1), Use in Specific Populations (8.4)].

WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS

See full prescribing information for complete boxed warning.

Increased risk of suicidal ideation, thinking, and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders (5.1).

SAVELLA is not approved for use in pediatric patients (1, 8.4).

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA022256 · Abbvie
First approved
January 14, 2009 (17 years ago)
Latest approved change
September 10, 2025
Approved label
PDF, Sep 11, 2025
Generic makers
3 approved generic applications on the market
Last patent listed
September 19, 2029

Savella questions

How much does savella cost without insurance?

Pharmacies pay about $244.50 for 30 tablets of savella 100 mg tablet ($8.15 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $291.68. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Savella?

Yes: milnacipran. Pharmacies pay from $36.45 for it. Compare milnacipran prices.

Is savella in shortage?

No shortage is reported for savella right now. We check the national shortage list every day.

Has savella been recalled?

No recalls are on record for savella.

When did the savella label last change?

The official label was last updated on August 27, 2026 (version 41). See what changed.

Talk about savella

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.